Shanghai Shyndec Pharmaceutical (600420.SH): Aminophylline Hydrochloride Tablets Passed Consistency Evaluation.

Shanghai Shyndec Pharmaceutical (600420.SH) announced that its wholly-owned subsidiary, Guoyao Group Shantou Jinshi Pharmaceutical Co., Ltd. (referred to as Guoyao Jinshi), received the Drug Supplement Application Approval Notice issued by the National Medical Products Administration, approving the Ammonium Chloride Bromhexine Hydrochloride tablets (30mg) through generic drug quality and efficacy consistency evaluation. Ammonium Chloride Bromhexine Hydrochloride is a new generation mucolytic agent that can improve sputum clearance and promote lung surfactant, airway secretion, and ciliary movement. It is widely used clinically in acute and chronic respiratory diseases with abnormal sputum secretion, especially in the treatment of chronic bronchitis, neonatal respiratory distress syndrome, and as an adjuvant therapy for pulmonary surgery. It has the advantages of low toxicity, definite efficacy, and good synergistic effects when used in combination with antibiotics, making it one of the most commonly used expectorants.